Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Convertible Debt (2016 - 2019)

Sanara MedTech (SMTI) has disclosed Convertible Debt for 9 consecutive years, with $1.5 million as the latest value for Q4 2019.

  • For the quarter ending Q4 2019, Convertible Debt changed N/A year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Dec 2019, changed N/A, and an annual FY2019 reading of $1.5 million, changed N/A over the prior year.
  • Convertible Debt was $1.5 million for Q4 2019 at Sanara MedTech, roughly flat from $1.5 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $1.5 million in Q3 2018 and bottomed at $1.2 million in Q4 2015.
  • Average Convertible Debt over 5 years is $1.3 million, with a median of $1.2 million recorded in 2015.
  • Peak annual rise in Convertible Debt hit 0.0% in 2016, while the deepest fall reached 0.0% in 2016.
  • Year by year, Convertible Debt stood at $1.2 million in 2015, then changed by 0.0% to $1.2 million in 2016, then changed by 0.0% to $1.2 million in 2017, then increased by 25.0% to $1.5 million in 2018, then changed by 0.0% to $1.5 million in 2019.
  • Business Quant data shows Convertible Debt for SMTI at $1.5 million in Q4 2019, $1.5 million in Q3 2019, and $1.5 million in Q2 2019.